Volume | 25,555 |
|
|||||
News | - | ||||||
Day High | 30.64 | Low High |
|||||
Day Low | 29.78 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Twist Bioscience Corporation | TWST | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
29.78 | 29.78 | 30.64 | 30.75 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
280 | 25,555 | $ 29.83 | $ 762,377 | - | 11.46 - 43.21 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
09:36:26 | 100 | $ 30.445 | USD |
Twist Bioscience (TWST) Options Flow Summary
Twist Bioscience Corporation Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
1.78B | 57.82M | - | 251.02M | -204.62M | -3.54 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Twist Bioscience News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical TWST Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 28.27 | 32.09 | 27.41 | 29.73 | 1,060,232 | 2.18 | 7.69% |
1 Month | 34.54 | 35.09 | 27.41 | 31.23 | 869,046 | -4.10 | -11.86% |
3 Months | 33.00 | 43.21 | 27.41 | 35.39 | 893,915 | -2.56 | -7.74% |
6 Months | 16.05 | 43.21 | 14.42 | 31.23 | 1,082,984 | 14.40 | 89.69% |
1 Year | 13.59 | 43.21 | 11.46 | 24.65 | 1,113,914 | 16.86 | 124.03% |
3 Years | 135.11 | 144.14 | 11.46 | 39.79 | 984,362 | -104.67 | -77.47% |
5 Years | 33.30 | 214.07 | 11.46 | 50.17 | 804,801 | -2.86 | -8.57% |
Twist Bioscience Description
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies and powers cost-effective, rapid high-throughput synthesis, enabling researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States. |